Higher mortality in women after ST-segment elevation myocardial infarction in very young patients

Marcin Sadowski1, Agnieszka Janion-Sadowska, Mariusz Gąsior

  • 1Świętokrzyskie Cardiology Centre, Kielce, Poland.

Insights

Young women under 40 experiencing ST-segment elevation myocardial infarction (STEMI) face higher long-term mortality than men. Despite similar risk factors and treatments like primary percutaneous coronary intervention (PCI), women

Area of Science:

  • Cardiology
  • Acute Coronary Syndromes
  • Gender Health Disparities

Background:

  • Mortality data for young ST-segment elevation myocardial infarction (STEMI) patients are conflicting.
  • Prognosis in women under 40 after STEMI requires further investigation.

Purpose of the Study:

  • To investigate the long-term prognosis of women under 40 following STEMI.
  • To compare mortality rates between young women and men after STEMI.

Main Methods:

  • Analysis of 527 STEMI patients aged 20-40 years from a nationwide registry.
  • Comparison of clinical characteristics, risk factors, and treatment strategies between genders.
  • Evaluation of in-hospital and 12-month mortality rates.

Main Results:

  • No significant gender differences in risk factors, clinical presentation, or reperfusion times.
  • High success rate for primary percutaneous coronary intervention (PCI) in both genders.
  • Significantly higher 12-month mortality in women (10.8%) compared to men (3.0%).

Conclusions:

  • Long-term mortality after STEMI is significantly higher in women under 40 than in men.
  • This disparity persists despite similar clinical profiles and management, including primary PCI.
  • Further research is needed to understand the underlying reasons for higher female mortality.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...